Suppr超能文献

介导皮肤同种异体移植排斥反应的淋巴细胞克隆分析。克隆的Lyt-1 + 2 - 增殖性、无细胞毒性长期细胞系在体内介导移植排斥反应。

Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.

作者信息

Kim B, Rosenstein M, Weiland D, Eberlein T J, Rosenberg S A

出版信息

Transplantation. 1983 Nov;36(5):525-32. doi: 10.1097/00007890-198311000-00011.

Abstract

Studies were undertaken to elucidate the cellular basis of skin allograft rejection mediated by long-term cultured cell lines and clones. The adoptive transfer, in vivo, of in-vitro-sensitized cells, from B6AF1 anti B10.BR or from C57BL/6 anti DBA/2 cultures, and expanded eight-fold to ten-fold for one week in lectin-free interleukin 2 (LF-IL-2) were able to mediate specific skin allograft rejection. These same cells lost the ability to mediate accelerated skin graft rejection when they were expanded more than 100-fold during three weeks of culture in LF-IL-2 even though these cultures mediated high levels of specific in vitro cytotoxicity for the appropriate allosensitizing cells. When Lyt-2+ cells were depleted using monoclonal antibodies and complement prior to in vitro sensitization and expansion in LF-IL-2, these cells lines retained the ability to mediate skin allograft rejection in vivo when expanded more than 100-fold for three culture generations in vitro. These latter lines were greatly enriched for Lyt-1+2- cells and had little or no cytolytic activity, but they retained specific in vitro proliferative responses to the sensitizing alloantigen. Several Lyt-1-2+ cloned long-term lymphoid cell lines with high levels of specific cytolytic activity against the sensitizing alloantigen were derived and none was capable of mediating the accelerated rejection of skin grafts in vivo. However, cloned lymphoid cell lines that were phenotypically Lyt-1+2- and were capable of proliferating when in contact with specific alloantigen, but were not cytolytic, were capable of mediating the accelerated rejection of skin grafts in vivo both in irradiated mice and in nude mice. These studies demonstrate that skin allograft rejection can be mediated by Lyt-1+2- cell lines with specific in vitro proliferative activity to alloantigen although Lyt-1-2+ cell lines with cytolytic but not proliferative activity to alloantigen in vitro are ineffective in mediating graft rejection in vivo. Specific proliferative activity and no cytolysis appears to be a good in vitro correlate of the in vivo activity of long-term cultured cell lines.

摘要

开展了多项研究以阐明长期培养的细胞系和克隆介导的皮肤同种异体移植排斥反应的细胞基础。将体外致敏细胞从B6AF1抗B10.BR或C57BL/6抗DBA/2培养物中进行体内过继转移,并在无凝集素白细胞介素2(LF-IL-2)中扩增8至10倍,持续一周,这些细胞能够介导特异性皮肤同种异体移植排斥反应。当这些相同的细胞在LF-IL-2中培养三周期间扩增超过100倍时,它们失去了介导加速皮肤移植排斥反应的能力,尽管这些培养物对合适的同种异体致敏细胞介导了高水平的特异性体外细胞毒性。当在体外致敏和在LF-IL-2中扩增之前使用单克隆抗体和补体去除Lyt-2+细胞时,这些细胞系在体外扩增超过100倍,经过三代培养后,仍保留在体内介导皮肤同种异体移植排斥反应的能力。后一种细胞系中Lyt-1+2-细胞大量富集,几乎没有或没有细胞溶解活性,但它们保留了对致敏同种异体抗原的特异性体外增殖反应。获得了几种对致敏同种异体抗原有高水平特异性细胞溶解活性的Lyt-1-2+克隆长期淋巴细胞系,但没有一种能够在体内介导皮肤移植加速排斥反应。然而,表型为Lyt-1+2-且在与特异性同种异体抗原接触时能够增殖但无细胞溶解作用的克隆淋巴细胞系,在辐照小鼠和裸鼠体内均能够介导皮肤移植加速排斥反应。这些研究表明,皮肤同种异体移植排斥反应可由对同种异体抗原有特异性体外增殖活性的Lyt-1+2-细胞系介导,尽管对同种异体抗原有细胞溶解活性但无体外增殖活性的Lyt-1-2+细胞系在体内介导移植排斥反应无效。特异性增殖活性且无细胞溶解作用似乎是长期培养细胞系体内活性的良好体外相关指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验